Prof. Dr. Carolin Hack



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Evaluating the potential of ChatGPT for patient identification in clinical breast cancer trials (2025) Krückel A, Fasching P, Schleicher O, Gocke J, Brückner L, Seitz K, Häberle L, et al. Journal article Invasive disease-free and overall survival after (neo)adjuvant chemotherapy in postmenopausal patients with hormone receptor-positive, HER2-negative early breast cancer treated with upfront letrozole: Experiences from the phase IV PreFace trial (2025) Beierlein M, Häberle L, Nabieva N, Maass N, Aktas B, Kümmel S, Thomssen C, et al. Journal article Integration von Komplementärmedizin in die Uroonkologie (2025) Hack C, Seitz K, Thederan I, Wüfling P, Wullich B, Bellut L, Herrmann HJ, Zopf Y Journal article Evaluation and feasibility of diagnostic heatflow imaging in patients with palpable breast lesions: a pilot study (2025) Pöschke P, Boese A, Seitz K, Amann N, Eckstein S, Schulmeyer C, Hack C, et al. Journal article A Digital Home-Based Health Care Center for Remote Monitoring of Side Effects During Breast Cancer Therapy: Prospective, Single-Arm, Monocentric Feasibility Study (2025) Hübner H, Wurmthaler L, Goossens C, Ernst M, Mocker A, Krückel A, Kallert M, et al. Journal article Correction to: Comparative assessment of breast volume using a smartphone device versus MRI (Breast Cancer, (2025), 32, 1, (166-176), 10.1007/s12282-024-01647-6) (2025) Behrens A, Hübner H, Häberle L, Stamminger M, Zint D, Heindl F, Emons J, et al. Journal article, Erratum Malignant upgrade in lesions of uncertain malignant potential in the breast (B3 lesions) – is open excision always necessary? (2025) Heindl F, Schiel J, Hack C, Amann N, Jud S, Preuss CI, Häberle L, et al. Journal article Prediction of pathological complete response after neoadjuvant chemotherapy for HER2-negative breast cancer patients with routine immunohistochemical markers. (2025) Häberle L, Erber R, Gaß P, Hein A, Niklos M, Volz B, Hack C, et al. Journal article The impact of physical activity on progression-free and overall survival in metastatic breast cancer based on molecular subtype (2024) Ziegler P, Hartkopf AD, Wallwiener M, Häberle L, Kolberg HC, Hadji P, Tesch H, et al. Journal article The Influence of Physical Training on Breast Cancer: The Role of Exercise-Induced Myokines in Regulating Breast Cancer Cell Growth and Survival (2024) Natarajan A, Pradhan R, Dieterich W, Schwappacher R, Reljic D, Herrmann HJ, Neurath M, et al. Journal article